CA Patent

CA3063208A1 — Foam-forming compositions for delivering an active to a body cavity

Assigned to Pharmiva AB · Expires 2018-11-29 · 7y expired

What this patent protects

Provided is a foam-forming formulation and method of administrating a medically active or cosmetic or reliving compound to the skin, to a would or to a body cavity. The foam-forming formulation contains monoglyceride crystals, a hydrophilic blowing agent in an amount to blow the …

USPTO Abstract

Provided is a foam-forming formulation and method of administrating a medically active or cosmetic or reliving compound to the skin, to a would or to a body cavity. The foam-forming formulation contains monoglyceride crystals, a hydrophilic blowing agent in an amount to blow the foam-forming composition and form a foam, water, and a medical, cosmetic or reliving compound. The foam-forming composition is suitable application to skin, wounds and body cavities when blown to form the foam and the foam melts at a body temperature to release the content. Also provided is a foam-forming composition vehicle for delivering an active agent.

Drugs covered by this patent

Patent Metadata

Patent number
CA3063208A1
Jurisdiction
CA
Classification
Expires
2018-11-29
Drug substance claim
No
Drug product claim
No
Assignee
Pharmiva AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.